for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Eu Biologics Co Ltd

206650.KQ

Latest Trade

6,410.00KRW

Change

-30.00(-0.47%)

Volume

425,681

Today's Range

6,350.00

 - 

6,750.00

52 Week Range

4,440.00

 - 

9,420.00

As of on the KOSDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
6,440.00
Open
6,420.00
Volume
425,681
3M AVG Volume
2.16
Today's High
6,750.00
Today's Low
6,350.00
52 Week High
9,420.00
52 Week Low
4,440.00
Shares Out (MIL)
26.79
Market Cap (MIL)
171,739.90
Forward P/E
-30.82
Dividend (Yield %)
--

Next Event

Eu Biologics Co Ltd Annual Shareholders Meeting

Latest Developments

More

Eu Biologics lowers exercise price of 1st series bonds with warrants to 6,596 won/share

Eu Biologics signs contract worth 13.48 bln won

Eu Biologics to buy land and building for 5.34 bln won

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Eu Biologics Co Ltd

EuBiologics Co., Ltd. is a Korea-based company principally engaged in manufacture and distribution of biopharmaceuticals. The Company also engaged in development of biopharmaceuticals and vaccine.

Industry

Biotechnology & Drugs

Contact Info

3-3, Bio Venture Town, 56, Soyanggang-ro

+82.2.5726675

http://www.eubiologics.com/

Executive Leadership

Yeong Ok Baek

Chief Executive Officer, Director

Seok Geun Choi

Vice President, Director

Gyeong Ho Min

Assistant Managing Director

Byeong Ho Choi

Internal Auditor

Yeong Sin Park

Assistant Managing Director

Key Stats

1.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, KRW)

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (KRW)

2017

-195.000

2018

151.000

2019(E)

-208.000
Price To Earnings (TTM)
--
Price To Sales (TTM)
6.03
Price To Book (MRQ)
5.72
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
107.10
LT Debt To Equity (MRQ)
72.40
Return on Investment (TTM)
-14.53
Return on Equity (TTM)
-11.06

Latest News

Latest News

BRIEF-Global Health Investment Fund I LLC buys 5.5 pct stake in EuBiologics

* Says Global Health Investment Fund I, LLC has acquired 1.3 million shares of the co, and is holding 5.5 percent stake in the co, from 0 percent stake

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up